{"id":153304,"date":"2020-12-10T18:13:41","date_gmt":"2020-12-10T23:13:41","guid":{"rendered":"https:\/\/www.one.org\/us\/?post_type=one_press&amp;p=153304"},"modified":"2020-12-10T18:13:41","modified_gmt":"2020-12-10T23:13:41","slug":"one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine","status":"publish","type":"one_press","link":"https:\/\/www.one.org\/us\/press\/one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine\/","title":{"rendered":"ONE reacts to FDA panel\u2019s recommendation of COVID-19 vaccine"},"content":{"rendered":"<p>WASHINGTON &#8211; The ONE Campaign released the following statement after the Food and Drug Administration\u2019s advisory panel voted to recommend the Pfizer\/BioNTech COVID-19 vaccine.<\/p>\n<p><b>Tom Hart, North America executive director at The ONE Campaign:<\/b><\/p>\n<p><span style=\"font-weight: 400\">\u201cThis is incredibly exciting news and is a big step towards the beginning of the end of this pandemic. Safe, effective vaccines will be key to ending the pandemic and reopening the global economy, but only if the most vulnerable, everywhere, have access to it. <\/span><span style=\"font-weight: 400\">If not, this virus will continue to cross borders and wreak havoc in the US and beyond.<\/span><\/p>\n<p><span style=\"font-weight: 400\">\u201cAs we look forward, the incoming Biden administration can take immediate steps to ensure we end this pandemic around the world by supporting global efforts to distribute vaccines and working with Congress to fund key partners like the Global Fund and Gavi.\u201d\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">Background:\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">The ONE Campaign\u2019s <\/span><a href=\"https:\/\/www.one.org\/international\/vaccine-access-test\/\"><span style=\"font-weight: 400\">Vaccine Access Test<\/span><\/a><span style=\"font-weight: 400\"> assesses how well deals between G20 governments and pharmaceutical companies further vaccine access. To date, the US government\u2019s actions have not been oriented toward global equity \u2013 it has not funded the ACT-Accelerator, not joined COVAX, and has not implemented policies that will improve access globally. If this strategy continues, it could cause an increase in the death toll and prolong the global economy crisis. <\/span><span style=\"font-weight: 400\">A recent <\/span><a href=\"https:\/\/www.rand.org\/pubs\/research_briefs\/RBA769-1.html\"><span style=\"font-weight: 400\">study<\/span><\/a><span style=\"font-weight: 400\"> found that if the world\u2019s poorest countries cannot access vaccines, the world could lose between $60 and $340 billion a year in GDP. For every $1 spent on supplying poorer countries with vaccines, high-income countries would get back about $4.80.<\/span><\/p>\n<div class=\"buffer\"><\/div>","protected":false},"excerpt":{"rendered":"<p>WASHINGTON &#8211; The ONE Campaign released the following statement after the Food and Drug Administration\u2019s advisory panel voted to recommend the Pfizer\/BioNTech COVID-19 vaccine. Tom Hart, North America executive director at The ONE Campaign: \u201cThis is incredibly exciting news and is a big step towards the beginning of the end of this pandemic. Safe, effective [&hellip;]<\/p>\n","protected":false},"author":17,"featured_media":0,"template":"","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"contributor":[],"class_list":["post-153304","one_press","type-one_press","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.1 (Yoast SEO v27.1.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>ONE reacts to FDA panel\u2019s recommendation of COVID-19 vaccine - ONE.org US<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.one.org\/us\/press\/one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ONE reacts to FDA panel\u2019s recommendation of COVID-19 vaccine\" \/>\n<meta property=\"og:description\" content=\"WASHINGTON &#8211; The ONE Campaign released the following statement after the Food and Drug Administration\u2019s advisory panel voted to recommend the Pfizer\/BioNTech COVID-19 vaccine. Tom Hart, North America executive director at The ONE Campaign: \u201cThis is incredibly exciting news and is a big step towards the beginning of the end of this pandemic. Safe, effective [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.one.org\/us\/press\/one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine\/\" \/>\n<meta property=\"og:site_name\" content=\"ONE.org US\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ONE\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.one.org\/us\/wp-content\/uploads\/sites\/2\/2023\/09\/GA_share_1200x628-768x402-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"768\" \/>\n\t<meta property=\"og:image:height\" content=\"402\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ONEinAmerica\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.one.org\/us\/press\/one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.one.org\/us\/press\/one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"ONE reacts to FDA panel\u2019s recommendation of COVID-19 vaccine\",\"datePublished\":\"2020-12-10T23:13:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.one.org\/us\/press\/one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine\/\"},\"wordCount\":263,\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.one.org\/us\/press\/one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine\/\",\"url\":\"https:\/\/www.one.org\/us\/press\/one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine\/\",\"name\":\"ONE reacts to FDA panel\u2019s recommendation of COVID-19 vaccine - ONE.org US\",\"isPartOf\":{\"@id\":\"https:\/\/www.one.org\/us\/#website\"},\"datePublished\":\"2020-12-10T23:13:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.one.org\/us\/press\/one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.one.org\/us\/press\/one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.one.org\/us\/press\/one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.one.org\/us\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ONE reacts to FDA panel\u2019s recommendation of COVID-19 vaccine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.one.org\/us\/#website\",\"url\":\"https:\/\/www.one.org\/us\/\",\"name\":\"ONE.org\",\"description\":\"Driving economic opportunities and healthy lives in Africa\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.one.org\/us\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"\",\"url\":\"https:\/\/www.one.org\/us\/stories\/author\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ONE reacts to FDA panel\u2019s recommendation of COVID-19 vaccine - ONE.org US","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.one.org\/us\/press\/one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine\/","og_locale":"en_US","og_type":"article","og_title":"ONE reacts to FDA panel\u2019s recommendation of COVID-19 vaccine","og_description":"WASHINGTON &#8211; The ONE Campaign released the following statement after the Food and Drug Administration\u2019s advisory panel voted to recommend the Pfizer\/BioNTech COVID-19 vaccine. Tom Hart, North America executive director at The ONE Campaign: \u201cThis is incredibly exciting news and is a big step towards the beginning of the end of this pandemic. Safe, effective [&hellip;]","og_url":"https:\/\/www.one.org\/us\/press\/one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine\/","og_site_name":"ONE.org US","article_publisher":"https:\/\/www.facebook.com\/ONE","og_image":[{"width":768,"height":402,"url":"https:\/\/www.one.org\/us\/wp-content\/uploads\/sites\/2\/2023\/09\/GA_share_1200x628-768x402-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@ONEinAmerica","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.one.org\/us\/press\/one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine\/#article","isPartOf":{"@id":"https:\/\/www.one.org\/us\/press\/one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine\/"},"author":{"name":"","@id":""},"headline":"ONE reacts to FDA panel\u2019s recommendation of COVID-19 vaccine","datePublished":"2020-12-10T23:13:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.one.org\/us\/press\/one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine\/"},"wordCount":263,"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.one.org\/us\/press\/one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine\/","url":"https:\/\/www.one.org\/us\/press\/one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine\/","name":"ONE reacts to FDA panel\u2019s recommendation of COVID-19 vaccine - ONE.org US","isPartOf":{"@id":"https:\/\/www.one.org\/us\/#website"},"datePublished":"2020-12-10T23:13:41+00:00","breadcrumb":{"@id":"https:\/\/www.one.org\/us\/press\/one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.one.org\/us\/press\/one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.one.org\/us\/press\/one-reacts-to-fda-panels-recommendation-of-covid-19-vaccine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.one.org\/us\/"},{"@type":"ListItem","position":2,"name":"ONE reacts to FDA panel\u2019s recommendation of COVID-19 vaccine"}]},{"@type":"WebSite","@id":"https:\/\/www.one.org\/us\/#website","url":"https:\/\/www.one.org\/us\/","name":"ONE.org","description":"Driving economic opportunities and healthy lives in Africa","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.one.org\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"","url":"https:\/\/www.one.org\/us\/stories\/author\/"}]}},"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"ONE.org US","distributor_original_site_url":"https:\/\/www.one.org\/us","push-errors":false,"_links":{"self":[{"href":"https:\/\/www.one.org\/us\/wp-json\/wp\/v2\/one_press\/153304","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.one.org\/us\/wp-json\/wp\/v2\/one_press"}],"about":[{"href":"https:\/\/www.one.org\/us\/wp-json\/wp\/v2\/types\/one_press"}],"author":[{"embeddable":true,"href":"https:\/\/www.one.org\/us\/wp-json\/wp\/v2\/users\/17"}],"version-history":[{"count":0,"href":"https:\/\/www.one.org\/us\/wp-json\/wp\/v2\/one_press\/153304\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.one.org\/us\/wp-json\/wp\/v2\/media?parent=153304"}],"wp:term":[{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/www.one.org\/us\/wp-json\/wp\/v2\/contributor?post=153304"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}